scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...745173T |
P356 | DOI | 10.1371/JOURNAL.PONE.0045173 |
P932 | PMC publication ID | 3441638 |
P698 | PubMed publication ID | 23028826 |
P5875 | ResearchGate publication ID | 231815170 |
P50 | author | Hans-Peter Kiem | Q88408730 |
Grant D Trobridge | Q117811734 | ||
Christina Ironside | Q117811737 | ||
P2093 | author name string | Punam Malik | |
Brian C Beard | |||
Robert A Wu | |||
P2860 | cites work | Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs. | Q50764646 |
A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice. | Q52167168 | ||
Hereditary persistence of fetal erythrocyte pyruvate kinase in the Basenji dog | Q67345971 | ||
Severe hereditary haemolytic anaemica in dogs treated by marrow trasplantation | Q67483375 | ||
Change of pyruvate kinase isozymes from M2- to L-type during development of the red cell | Q70436575 | ||
Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine | Q72789943 | ||
Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency | Q73101638 | ||
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study | Q78138460 | ||
Gene therapy for the hemoglobin disorders | Q80914842 | ||
The human genome browser at UCSC | Q24672361 | ||
The UCSC Genome Browser Database | Q27861125 | ||
K562—A human erythroleukemic cell line | Q28302796 | ||
Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme | Q33622730 | ||
Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency | Q33688423 | ||
Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates. | Q33968014 | ||
Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors | Q34032399 | ||
Characterization of a newly derived human sarcoma cell line (HT-1080). | Q34202593 | ||
Foamy virus vector integration sites in normal human cells | Q34334976 | ||
Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo | Q35182775 | ||
Foamy-virus-mediated gene transfer to canine repopulating cells | Q35615750 | ||
Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors | Q36713507 | ||
In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene | Q37241374 | ||
A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses | Q40022227 | ||
Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model | Q40156537 | ||
Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. | Q40651725 | ||
Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency | Q41473948 | ||
Animal model of human disease: pyruvate kinase deficiency | Q41475115 | ||
Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy | Q43600838 | ||
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors | Q43775876 | ||
Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia | Q44678059 | ||
Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency | Q44779183 | ||
Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells | Q45007190 | ||
Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy | Q45115057 | ||
Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors | Q45676086 | ||
Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors | Q45736388 | ||
The molecular basis of canine pyruvate kinase deficiency | Q45866242 | ||
Hematopoietic stem cell transduction and amplification in large animal models | Q45889541 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e45173 | |
P577 | publication date | 2012-09-13 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency | |
P478 | volume | 7 |
Q47162946 | A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice |
Q37580086 | Efficiency and safety of O⁶-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model |
Q37033208 | Erythrocyte pyruvate kinase deficiency in three West Highland white terriers in Ireland and the UK |
Q90597095 | FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs |
Q35812028 | Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection |
Q26859020 | Foamy virus vectors for HIV gene therapy |
Q64914676 | In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. |
Q38808141 | Insulated Foamy Viral Vectors |
Q55333613 | Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies. |
Q30409845 | Intravenous injection of a foamy virus vector to correct canine SCID-X1. |
Q36482767 | Large animal models for foamy virus vector gene therapy |
Q50878341 | Prospects for Foamy Viral Vector Anti-HIV Gene Therapy. |
Q40772336 | Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency |
Search more.